Allurion Technologies Inc.

    Jurisdiction
    United States
    ISIN
    US02008G2012 (ALUR)
    Sectors
    1. Healthcare
    2. Medical - Devices

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    1 / 9

    Profile

    Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €17.09M
    Gross margin
    61.8%
    EBIT
    -€37.49M
    EBIT margin
    -219.4%
    Net income
    -€27.05M
    Net margin
    -158.3%

    Statement period: - (published )

    Dividends

    No dividend payouts

    Earnings Calls

    Latest earnings call: August 13, 2025

    Add to watchlist

    Notifications